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ORIGINAL RESEARCH
Exercise- Based Cardiac Rehabilitation and 
All- Cause Mortality Among Patients With 
Atrial Fibrillation
Benjamin J. R. Buckley , PhD; Stephanie L. Harrison, PhD; Elnara Fazio- Eynullayeva, MA;  
Paula Underhill; Deirdre A. Lane, PhD; Dick H. J. Thijssen , PhD; Gregory Y. H. Lip , MD
BACKGROUND: There is limited evidence of long- term impact of exercise- based cardiac rehabilitation (CR) on clinical end points 
for patients with atrial fibrillation (AF). We therefore compared 18- month all- cause mortality, hospitalization, stroke, and heart 
failure in patients with AF and an electronic medical record of exercise- based CR to matched controls.
METHODS AND RESULTS: This retrospective cohort study included patient data obtained on February 3, 2021 from a global 
federated health research network. Patients with AF undergoing exercise- based CR were propensity- score matched to pa-
tients with AF without exercise- based CR by age, sex, race, comorbidities, cardiovascular procedures, and cardiovascular 
medication. We ascertained 18- month incidence of all- cause mortality, hospitalization, stroke, and heart failure. Of 1 366 422 
patients with AF, 11 947 patients had an electronic medical record of exercise- based CR within 6- months of incident AF who 
were propensity- score matched with 11 947 patients with AF without CR. Exercise- based CR was associated with 68% lower 
odds of all- cause mortality (odds ratio, 0.32; 95% CI, 0.29– 0.35), 44% lower odds of rehospitalization (0.56; 95% CI, 0.53– 
0.59), and 16% lower odds of incident stroke (0.84; 95% CI, 0.72– 0.99) compared with propensity- score matched controls. No 
significant associations were shown for incident heart failure (0.93; 95% CI, 0.84– 1.04). The beneficial association of exercise- 
based CR on all- cause mortality was independent of sex, older age, comorbidities, and AF subtype.
CONCLUSIONS: Exercise- based CR among patients with incident AF was associated with lower odds of all- cause mortality, re-
hospitalization, and incident stroke at 18- month follow- up, supporting the provision of exercise- based CR for patients with AF.
Key Words: arrhythmia ■ cardiovascular disease ■ cohort study ■ multimorbidity ■ preventive cardiology
Cardiac rehabilitation (CR) and exercise promote secondary prevention of cardiovascular disease and associated adverse events. Exercise- based 
CR is therefore an essential component of routine care 
for patients with acute coronary syndrome, those un-
dergoing revascularization (coronary artery bypass 
graft or percutaneous coronary intervention), and 
those with heart failure.1,2 In patients with coronary 
heart disease, exercise- based CR has been shown to 
improve exercise capacity, health- related quality of life, 
reduce hospitalizations, and depending on the source 
of evidence, reduce all- cause or cardiovascular- related 
mortality.3
Regular exercise has been shown to have po-
tent protective effects in the primary and secondary 
prevention of atrial fibrillation (AF).4 For example, ex-
ceeding 500 metabolic equivalent mins/week (METs) 
has been associated with reduced risk of incident 
AF.5 In addition, greater cardiorespiratory fitness was 
associated with increased freedom of AF and for 
every 1 MET increase in cardiorespiratory fitness, AF 
recurrence was reduced by 9%.6,7 One randomized 
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controlled trial compared CR to usual care for 210 pa-
tients treated with catheter ablation for AF.8 Findings 
revealed a significantly higher (≈1 MET) cardiorespi-
ratory fitness at 4 months in CR compared with usual 
care. Despite such promising evidence for the ben-
eficial effect of exercise as secondary prevention for 
patients with AF, exercise- based CR is not part of 
any routine care pathways for patients with AF. In ad-
dition, there is currently no evidence of the long- term 
impact of exercise- based CR on important clinical 
end points for patients with AF.9
Using a large online database, we explored the hy-
pothesis that exercise- based CR is associated with 
reduced all- cause mortality, rehospitalization, and car-
diovascular morbidity in patients with AF. Therefore, 
the aim of the present study, using a global federated 
health research network, was to compare 18- month 
all- cause mortality, rehospitalization, stroke, and heart 
failure in patients with AF and an electronic medical 
record (EMR) of exercise- based CR to propensity- 




To gain access to the data in the TriNetX research net-
work, a request can be made to TriNetX (https://live.
trine tx.com), but costs may be incurred, a data sharing 
agreement would be necessary, and no patient identi-
fiable information can be obtained.
Study Design and Participants
This retrospective observational study was con-
ducted with data provided by TriNetX, a global 
federated health research network with access to 
EMRs from participating academic medical cent-
ers, specialty physician practices, and commu-
nity hospitals, predominantly in the United States. 
Patients with AF were identified in TriNetX based on 
Centers for Disease Control and Prevention coding.10 
AF was identified from International Classification 
of Diseases, Ninth and Tenth Revisions, Clinical 
Modification (ICD- 9- CM and ICD- 10- CM) codes in 
patient EMRs: I48 (atrial fibrillation and flutter), I48.0 
(paroxysmal AF), I48.1 (persistent AF), and I48.21 
(permanent AF). Exercise- based CR was identified 
from ICD- 10- CM codes Z71.82 (exercise counseling), 
Healthcare Common Procedure Coding System 
code S9472 (CR program, non- physician provider, 
per diem), or Current Procedures Terminology code 
1013171 (physician or other qualified healthcare pro-
fessional services for outpatient CR). Diagnoses in 
TriNetX are represented by ICD- 10- CM codes. If a 
healthcare organization provided data in ICD- 9- CM, 
TriNetX uses a 9- to- 10- CM mapping based on gen-
eral equivalence mappings plus custom algorithms 
and curation to transform data from ICD- 9- CM to 
ICD- 10- CM. These exercise- based CR codes were 
used as exclusion criteria in the PSM control cohorts. 
This study is reported as per the Strengthening the 
Reporting of Observational Studies in Epidemiology 
guidelines and the checklist can be found as a sup-
plement (Table S1).11
As a federated network, research studies using the 
TriNetX network do not require ethical approval or pa-
tient informed consent as no patient identifiable infor-
mation is received.
Data Collection
The TriNetX network was searched on February 
3, 2021 and an anonymized data set from 2009 to 
2020 of patients with incident AF was analyzed. The 
exercise- based CR cohort were aged ≥18 years with 
CR and/or exercise programs recorded in EMRs 
within 6 months of an incident AF diagnosis. Controls 
were aged ≥18  years with a diagnosis of AF and no 
history of exercise- based CR in EMRs. For both the 
CLINICAL PERSPECTIVE
What Is New?
• We investigated the association of exercise- 
based cardiac rehabilitation on all- cause mor-
tality, rehospitalization, incident stroke, and 
incident heart failure in patients with atrial 
fibrillation.
• In this retrospective cohort study of 23  894 
patients with incident atrial fibrillation, exercise- 
based cardiac rehabilitation was associated 
with 68% lower odds of all- cause mortality, 
44% lower odds of rehospitalization, and 16% 
lower odds of incident stroke, compared with 
propensity- matched controls at 18- month 
follow- up.
What Are the Clinical Implications?
• Exercise- based cardiac rehabilitation may be 
beneficial for patients with atrial fibrillation on 
important clinical end points, supporting the in-
clusion of patients with incident atrial fibrillation 
for exercise- based interventions.
Nonstandard Abbreviations and Acronyms
CR cardiac rehabilitation
EMR electronic medical record
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exercise- based CR cohort and controls, patients with 
AF were identified in EMRs from at least 18 months 
before the search date to ensure a minimum follow-
 up of 18 months from AF diagnosis (12 months from 
CR). At the time of the search, 41 participating health-
care organizations had data available for patients who 
met the study inclusion criteria. Thus, following PSM, 
the cohort consisted of patients with AF who either 
were referred for exercise- based CR (because of car-
diovascular disease) within 6 months of an incident 
AF diagnosis (intervention) or were not referred for 
exercise- based CR (control).
Statistical Analysis
All statistical analyses were completed on the TriNetX 
online platform. Baseline characteristics were com-
pared using Chi- squared tests for categorical vari-
ables and independent- sample t tests for continuous 
variables. Current CR provision is typically reserved 
for cardiovascular patients following an acute coro-
nary syndrome, those undergoing a revascularization 
procedure (coronary artery bypass graft or planned 
percutaneous coronary intervention), and patients 
with heart failure. Thus, PSM was used to control 
for these differences in the 2 cohorts. Patients with 
exercise- based CR and controls were 1:1 PSM using 
logistic regression for age at AF diagnosis, sex, race, 
hypertensive diseases, ischemic heart diseases, heart 
failure, cerebrovascular diseases, diabetes mellitus, 
chronic kidney disease, respiratory diseases, nervous 
system diseases, neoplasms, cardiovascular proce-
dures (eg, cardiography, echocardiography, cardiac 
catheterization, revascularization [eg, percutaneous 
coronary intervention or coronary artery bypass graft], 
cardiac devices, electrophysiological procedures), and 
cardiovascular medications (eg, beta- blockers, antiar-
rhythmics, diuretics, antilipemic agents, antianginals, 
calcium channel blockers, angiotensin- converting 
enzyme inhibitors). These variables were chosen be-
cause they are established risk factors for AF and/or 
mortality or were significantly different between the 2 
cohorts.12 The TriNetX platform uses "greedy nearest- 
neighbour matching" with a caliper of 0.1 pooled SDs. 
Following PSM, logistic regressions produced odds 
ratios (ORs) with 95% CIs for 18- month incidence of 
all- cause mortality, hospitalization, stroke, and heart 
failure, comparing exercise- based CR with controls. 
These outcomes were based on ICD- 10- CM codes in 
patient EMRs. Additional sub- analyses (following PSM) 
were conducted to produce ORs with 95% CIs to ex-
plore the effect of some population subgroups (sex, 
body mass index, history of cardiovascular events, 
and AF subtype) on the odds of all- cause mortality 
between the exercise- based CR cohort and controls. 
Statistical significance was set at P<0.05.
RESULTS
Patient Characteristics
In total, 1 366 422 patients from 41 healthcare organiza-
tions had a diagnosis of AF at least 18 months before 
the search date of which, 12 315 (0.9%) had an EMR of 
exercise- based CR within 6 months of diagnosis. The 
exercise- based CR cohort was distributed between the 
4 large Census Bureau designated regions of the United 
States as follows: 6% (n=739) in the Northeast, 30% 
(n=3695) in the Midwest, 33% (n=4064) in the South, 27% 
(n=3325) in the West, and 5% (n=616) were unknown. 
The control cohort was also distributed between the 4 
large Census Bureau designated regions of the United 
States as follows: 17% (n=230  198) in the Northeast, 
19% (n=257 280) in the Midwest, 43% (n=582 266) in 
the South, 8% (n=108 329) in the West, 1% (n=13 541) 
non- United States, and 12% (n=162 493) were unknown.
Compared with controls, the exercise- based CR 
cohort was younger, had a lower proportion of fe-
males, had a higher proportion of people identified as 
White, and had a higher proportion of patients with 
health conditions, history of cardiovascular proce-
dures, and use of cardiovascular medications. These 
variables were included in subsequent PSM analyses. 
Table  1 shows the characteristics of the exercise- 
based CR cohort and controls both before and fol-
lowing 1:1 PSM. Following 1:1 PSM, there were 11 947 
patients in each cohort (n=23 894 patients included in 
analyses), which were overall well balanced.
Clinical Outcomes
Following PSM, 18- month all- cause mortality was 
6.1% (n=721 of 11 909 patients) in the exercise- based 
CR cohort and 16.8% (n=1965 of 11 713 patients) in 
the matched controls (P<0.0001). Logistic regression 
models showed 68% lower odds of all- cause mortality 
(OR, 0.32; 95% CI, 0.29– 0.35) in the exercise- based 
CR cohort compared with controls; 18- month hospi-
talization rate was 33.3% (n=3974 of 11 947 patients) 
in the exercise- based CR cohort and 47.0% (n=5616 
of 11 947 patients) in the matched controls (P<0.0001). 
Logistic regression models showed exercise- based 
CR was associated with 44% lower hospitalizations 
(OR, 0.56; 95% CI 0.53– 0.59) compared with con-
trols; 18- month incident stroke rate was 2.8% (n=310 
of 11 071 patients) in the exercise- based CR cohort 
and 3.3% (n=351 of 10 638 patients) in the matched 
controls (P=0.003). Logistic regression models 
showed 16% lower odds of incident stroke (OR, 0.84; 
95% CI, 0.72– 0.99) in the exercise- based CR cohort 
compared with controls. No significant difference was 
found between the exercise- based CR cohort and 
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Subgroup Analyses
Following PSM, subgroup logistic regression analyses 
demonstrated that exercise- based CR was associated 
with lower all- cause mortality compared with con-
trols for all included subgroups: women, men; aged 
≥75 years, aged <75 years; obese, not obese; history 
of stroke, no history of stroke; history of acute myocar-
dial infarction, no history of acute myocardial infarction; 
and paroxysmal AF, persistent AF, and permanent AF 
(Figure).
DISCUSSION
This is the first study to demonstrate that exercise- 
based CR was associated with lower odds of all- 
cause mortality, rehospitalization, and stroke in 
a large cohort of patients with AF. Primarily, the 
present study of 23  894 patients with incident AF 
demonstrated that exercise- based CR associates 
with 68% lower odds of all- cause mortality com-
pared with PSM controls. Second, the beneficial as-
sociation of exercise- based CR with lower all- cause 
mortality was independent of sex, older age, obesity, 
history of stroke, history of acute myocardial infarc-
tion, and AF subtype. Collectively, this retrospective 
analysis represents the first follow- up data set of its 
kind for incident AF, strongly supporting the clinical 
value of exercise- based CR following an AF diagno-
sis, and highlighting the need for controlled clinical 
trials on this topic.
Cardiac Rehabilitation and All- Cause 
Mortality
Not specific for patients with AF, exercise- based CR 
is recommended (with the highest level of scien-
tific evidence— class I) by the European Society of 
Table 1. Baseline Characteristics %(n)* of the AF Populations With and Without CR and Exercise Before and After 
Propensity- Score Matching
Initial Populations Propensity Score Matched Populations
AF Without CR 
(n=1 354 107)
AF With CR 
(n=12 315) P Value
AF Without CR 
(n=11 947)
AF With CR 
(n=11 947) P Value
Age (y) at diagnoses; mean (SD) 70.4 (13.4) 67.4 (12.1) <0.0001 67.5 (12.4) 67.6 (12.0) 0.45
Sex
Male 55.9 (757 103) 70.8 (8715) <0.0001 70.7 (8443) 70.3 (8395) 0.50
Female 44.1 (596 688) 29.2 (3600) <0.0001 29.3 (3502) 29.7 (3552) 0.48
Race
White 78.9 (1 068 111) 83.8 (10 320) <0.0001 84.1 (10 047) 83.6 (9992) 0.33
Black 7.8 (10 877) 7.3 (894) <0.0001 7.8 (930) 7.4 (885) 0.27
Asian 1.3 (17 910) 1.4 (172) <0.0001 1.2 (147) 1.4 (167) 0.26
Unknown 11.7 (158 502) 6.9 (852) 0.021 6.3 (754) 7.0 (836) 0.033
Comorbidities
Ischaemic heart diseases 11.9 (161 368) 78.8 (9703) 0.47 80.2 (9578) 78.2 (9342) <0.001
Hypertensive diseases 24.8 (335 777) 78.1 (9614) <0.0001 77.3 (9234) 77.6 (9270) 0.58
Diseases of the respiratory 
system
16.1 (217 935) 66.6 (8203) <0.0001 64.7 (7726) 65.8 (7864) 0.06
Diseases of the nervous system 15.1 (204 010) 54.1 (6659) <0.0001 51.3 (6134) 53.2 (6355) 0.004
Heart failure 7.6 (103 547) 48.7 (6001) <0.0001 48.8 (5826) 47.8 (5709) 0.13
Diabetes mellitus 10.8 (146 298) 35.0 (4312) <0.0001 33.8 (4043) 34.8 (4152) 0.14
Chronic kidney disease 6.0 (81 454) 23.1 (2841) <0.0001 22.7 (2717) 23.0 (2745) 0.67
Cerebrovascular diseases 5.2 (70 372) 22.0 (2707) <0.0001 20.5 (2450) 21.7 (2587) 0.030
Neoplasms 10.9 (147 783) 20.7 (2551) <0.0001 18.8 (2249) 20.9 (2491) <0.001
Cardiovascular care
Cardiovascular procedures† 22.8 (308 994) 90.3 (11 118) <0.0001 89.7 (10 711) 90.0 (10 750) 0.40
Cardiovascular medications‡ 35.7 (482 867) 91.8 (11 311) <0.0001 90.9 (10 865) 91.6 (10 943) 0.07
AF indicates atrial fibrillation; and CR, cardiac rehabilitation and exercise programmes.
*Values are % (n) unless otherwise stated. Baseline characteristics were compared using a 𝛘2 test for categorical variables and an independent- sample t- test 
for continuous variables. Data are taken from structured fields in the electronic medical record systems of the participating healthcare organizations, therefore, 
there may be regional or country- specific differences in how categories are defined.
†Cardiovascular procedures include cardiography, echocardiography, catheterization, cardiac devices, electrophysiological procedures.
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Cardiology,13 the American Heart Association, and 
the American College of Cardiology.14 These global 
recommendations are supported by studies that find 
CR- related improvements in exercise capacity, health- 
related quality of life, and reductions in hospital ad-
missions.15,16 Findings related to all- cause mortality, 
however, are less clear. In contrast to earlier Cochrane 
meta- analyses,15,17 the most recent Cochrane system-
atic review and meta- analysis of 63 studies (14  846 
participants)16 did not observe a statistically significant 
reduction in all- cause mortality following exercise- 
based CR in patients with coronary heart disease com-
pared with no- exercise controls. However, real- world 
data studies have found exercise- based CR to be as-
sociated 32% to 90% lower odds of all- cause mortality 
when compared with PSM controls.18– 20
Importantly, the previously discussed studies fo-
cused on patients other than those with AF. Indeed, 
exercise- based CR is not part of routine care for pa-
tients diagnosed with AF. It is therefore important to 
note that the exercise- based CR cohort in the present 
study presented with a high proportion of patients with 
multiple cardiovascular comorbidities. This is because 
current exercise- based CR provision is reserved for 
patients following an acute coronary syndrome, those 
undergoing a revascularization procedure (coronary 
artery bypass graft or planned percutaneous coronary 
intervention), and heart failure. Thus, PSM was used to 
control for these differences in the 2 cohorts. The find-
ings of the present study are therefore the first encour-
aging evidence for the provision of exercise- based CR 
for patients newly diagnosed with AF for lower odds 
of all- cause mortality, rehospitalization, and stroke 
(Table 2 and Figure).
AF- Specific Cardiac Rehabilitation
The relationship between physical activity and AF has 
been somewhat counterintuitive, with some evidence 
supporting an association between exercise training 
and the occurrence of AF.4 Nonetheless, given ex-
ercise provides a promising first line treatment for 
Table 2. Major Adverse Events and New Onset Health 
Conditions at 18- Month Follow- Up From Incident AF 
Diagnosis; Comparing Patients With AF Who Received 
Exercise- Based CR (n=11 947) With Patients With AF Who 
Received Usual Care Only (n=11 947)
Odds Ratio 95% CI P Value
Major adverse events
All- cause mortality 0.32 0.29– 0.35 <0.0001
Hospitalization 0.56 0.53– 0.59 <0.0001
Stroke 0.84 0.72– 0.99 0.032
New onset conditions
Heart failure 0.93 0.84– 1.04 0.20
AF indicates atrial fibrillation; and CR, cardiac rehabilitation.
Figure. Subgroup- specific odds ratios for all- cause mortality at 18- month follow- up from incident atrial fibrillation 
diagnosis; comparing patients with atrial fibrillation who received exercise-based cardiac rehabilitation with matched 
patients with atrial fibrillation who received usual care only (controls).
Sample size is number of patients in analysis with and without post- incident atrial fibrillation diagnosis cardiac rehabilitation, following 
propensity- score matching. AF indicates atrial fibrillation; AMI, acute myocardial infarction; BMI, body mass index; and CR, cardiac 
rehabilitation and exercise programs.
0 0.5 1 1.5
Odds Rao (95% CI)
 
Subgroup n=parcipants Odds Rao 95% CI P-value 
Total cohort 21,250 0.36 0.33-0.40 <0.0001 
Female 6,282 0.39 0.33-0.46 <0.0001 
Male 14,962 0.34 0.31-0.38 <0.0001 
Aged >75 years 9,202 0.39 0.35-0.45 <0.0001 
Aged <75 years 12,756 0.32 0.28-0.36 <0.0001 
BMI >30 5,892 0.38 0.32-0.45 <0.0001 
BMI <30 7,824 0.47 0.41-0.54 <0.0001 
History of stroke 816 0.39 0.25-0.61 <0.0001 
No history of stroke 20,436 0.35 0.32-0.39 <0.0001 
History of AMI 2,560 0.28 0.21-0.37 <0.0001 
No history of AMI 18,690 0.37 0.34-0.41 <0.0001 
Paroxysmal AF 8,954 0.32 0.27-0.37 <0.0001 
Persistent AF 2,728 0.43 0.34-0.54 <0.0001 
Permanent AF 3,226 0.48 0.39-0.58 <0.0001 
Sample size is number of paents in analysis with and without post-incident AF diagnosis CR , following propensity score 
matching. 
CR; cardiac rehabilitaon and exercise programmes, AF; atrial fibrillaon, 95% CI; 95% confidence interval, BMI; body mass 
index, AMI; acute myocardial infarcon.  
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individuals diagnosed with AF, associated with en-
hanced quality of life,21 AF- specific outcomes,22 re-
duced secondary cardiovascular events,23 and more 
recently lower odds of AF subtype progression,24 
one may expect a reduction in all- cause mortality 
following exercise- based CR. However, 2 previous 
systematic reviews and meta- analyses, Risom et al9 
and Smart et al,25 did not find a reduction in all- cause 
mortality following CR for patients with AF; Smart et 
al25 did report improvements in AF symptom burden, 
health- related quality of life, exercise capacity, and 
cardiac function. Given the small number of available 
intervention studies (9 randomized controlled trials 
with 959 participants) and heavy weighting on one 
trial for mortality outcome analyses (97.9%), it may 
not be surprising that no effects for all- cause mortal-
ity were found.
One previous large multicenter observational study 
(EuroObservational Research Programme AF Long 
term General Registry) analyzed the relationship be-
tween physical activity and major adverse outcomes 
in 2 442 patients with AF.26 Aligned with the findings 
of the present paper, not only was all- cause mortality 
lower in “regular” and “intense” physical activity co-
horts, but all patient subgroups were associated with 
lower all- cause mortality compared with no physical 
activity.
Older patients are typically underrepresented in 
CR despite a higher disease prevalence.27 Given the 
heightened risk of mortality in older patients, it is prom-
ising that exercise- based CR was associated with a 
significantly lower all- cause mortality (61%) for patients 
aged ≥75 years in the present study. This magnitude 
is largely agreeable with previous real- world data in a 
more broad cardiovascular patient cohort.18– 20 This is 
particularly important in patients with AF, given preva-
lence increases from 2% to 20% in people >80 years.28 
Similarly, female patients are less likely to be referred to 
CR29 and our findings are promising given both male 
and female patients with AF were associated with re-
duced all- cause mortality with exercise- based CR. 
This is particularly important given women with AF 
have a 2- fold increased risk of mortality compared with 
non- AF comparisons, higher than that attributable to 
men (1.5- fold increased risk).30 It is therefore vital that 
access to CR and exercise programs are equitable, re-
gardless of sex and age.
Finally, our findings demonstrate significant associ-
ations of lower all- cause mortality following exercise- 
based CR, stratified for AF subtype. Although a 
non- linear relationship between AF and exercise 
seems likely (with guideline exercise levels associated 
with reduced incident AF and chronic excessive en-
durance exercise associated with increased AF prev-
alence),4 the 2020 European Society of Cardiology 
guidelines for AF encourage patients to undertake 
moderate- intensity exercise and remain physically ac-
tive to prevent AF incidence or recurrence.31 However, 
the effect of exercise- based CR on major adverse car-
diovascular events is uncertain.31 To our knowledge, 
our findings are therefore the first promising evidence 
suggesting exercise- based CR is associated with 
lower odds of mortality and serious adverse events 
in patients with incident AF. Interventional research 
via appropriately powered randomized- controlled tri-
als investigating the effects of exercise- based CR is 
warranted.
Limitations
A number of limitations are noteworthy. First, the 
data were collected from healthcare organization 
EMR databases and some comorbidities may be 
underreported, and ethnicity was not available for 
all participants. Indeed, recording of ICD codes in 
administrative data sets may vary by factors such 
as age, number of comorbidities, severity of illness, 
length of hospitalization, and whether in- hospital 
death occurred.32 In particular, an EMR of CR and ex-
ercise does not necessarily provide information as to 
whether a participant attended, the intervention type 
and dose, or intervention adherence— this is an im-
portant limitation to this type of data. Nor do we have 
patient physical activity levels following the interven-
tion, which would be an interesting outcome. Second, 
the data were from multiple healthcare organizations 
in the United States but may not be representative 
of the wider population. Third, despite efforts to con-
trol for several important patient characteristics using 
PSM, residual confounding may have impacted our 
results, including lifestyle factors (such as baseline fit-
ness and physical activity levels), socioeconomic sta-
tus, disease severity, and quality of care, which are 
not obtainable from EMRs. For more information on 
this, please refer to the linked reference.33 Fourth, it 
was not possible to factor for multiple comparisons 
in the subgroup analyses within the online database. 
Finally, the observed benefit of exercise- based CR in 
the present study is a potential function of improved 
management and outcomes related to cardiovascular 
comorbidity, rather than improvement to the AF sub-
strate itself. However, given prior work by our group 
has also demonstrated lower odds of progression 
from paroxysmal to sustained AF with exercise- based 
CR compared with matched controls,24 it is promis-
ing that such substantial benefits may be realized via 
exercise- based CR in a real- world cohort of patients 
with AF and substantial cardiovascular comorbidity. 
Nevertheless, subsequent randomized- controlled 
trials are needed to further investigate the impact of 
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CONCLUSIONS
Participation in exercise- based CR in 23 894 patients 
with incident AF was associated with a reduction in all- 
cause mortality, rehospitalization, and incident stroke 
at 18- months following AF diagnosis. The survival ben-
efit associated with exercise- based CR was consist-
ent across all patient subgroups and AF subtypes. The 
findings of the present study therefore support the pro-
vision of exercise- based CR for patients with incident 
AF and warrant further prospective research.
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